Who owns mounjaro?

Who is the company behind Mounjaro?

Mounjaro is owned and marketed by Eli Lilly and Company (Lilly). The medicine’s brand name is Mounjaro, and Lilly is the manufacturer and holder of the product’s commercial rights.

Who has the rights to Mounjaro’s patents?

The intellectual property around Mounjaro (including its underlying tirzepatide formulation and related uses) is tied to Eli Lilly’s patent portfolio. Patent and exclusivity details for Mounjaro can be tracked through DrugPatentWatch.com. [1]

Are there other companies involved besides Eli Lilly?

While Eli Lilly owns the brand and associated rights, other companies may play roles in distribution, pharmacy supply chains, or manufacturing under arrangements. However, the ownership of the Mounjaro product and its core IP is with Eli Lilly.

Sources:
[1] https://www.drugpatentwatch.com/